IPITA-IXA-CTRMS 2023 Joint Congress

Abstract Submission Deadline: April 3

Don’t miss the chance to submit your abstract to the IPITA-IXA-CTRMS 2023 Joint Congress!

Submission deadline: April 3, 2023
Registration: Presenters must be registered and have paid their registration fee by July 24, 2023; otherwise, the abstract will be removed from the program.
ONLY accepted abstracts by a presenter registered to attend the Congress will be published in an online supplement of the Transplantation Journal.
It is the submitter’s responsibility to ensure that all co-authors approve of the abstract’s submission, publication, and potential presentation.

CLICK HERE TO SUBMIT YOUR ABSTRACT

Congress Scientific Abstract Travel Awards

The IPITA, IXA, CTRMS and TTS are pleased to announce there will opportunities for Trainees, Allied Health Professionals and residents of Emerging Economies to apply for scientific abstract travel awards.

The awards of each Society are designed to help offset expenses incurred to attend the Joint Congress and are awarded based on the scientific merit of the applicants abstract. Recipients must attend the meeting in order to receive the award and must be a member in good standing of the Society award for which they are applying.

We would like to thank eGenesis for their generous support of an unrestricted educational grant to support additional Abstract Travel awards for the Congress.

CLICK HERE TO VISIT THE AWARDS PAGE

Transplantation Updates

Transplantation - Highlighted Tweets

Trifecta (ClinicalTrials.gov #NCT04239703) is a prospective trial defining relationships between donor-derived cell-free DNA (dd-cfDNA), donor-specific antibody (DSA), and molecular findings in kidney transplant biopsies. Previous analyses of double results showed dd-cfDNA was strongly associated with rejection-associated molecules in the biopsy. The present study analyzed the triple results in 280 biopsies, focusing on the question of dd-cfDNA levels in DSA-negative antibody-mediated rejection (AMR).

Isavuconazole has theoretical advantages over other mold-active triazoles for the treatment of invasive aspergillosis and mucormycosis after solid organ transplantation (SOT). The available clinical experience, nevertheless, is scarce. We performed a retrospective study including all adult SOT recipients with proven or probable invasive mold disease (IMD) that received isavuconazole for ≥24 h as first-line or salvage therapy at 10 Spanish centers between September 2017 and November 2021.

Transplantation Direct - Highlighted Tweet

Kidney transplant recipients (KTRs) have a diminished response to SARS-CoV-2 vaccination compared with immunocompetent individuals. Deeper understanding of antibody responses in KTRs following third-dose vaccination would enable identification of those who remain unprotected against Omicron.

Maintenance immunosuppression with belatacept following kidney transplantation results in improved long-term graft function as compared with calcineurin inhibitors. However, broad application of belatacept has been limited, in part related to logistical barriers surrounding a monthly (q1m) infusion requirement.

Upcoming Webinar Presentation

CLICK HERE FOR DETAILS AND TO REGISTER

Women in Transplantation Research Grants

Application Deadline: April 1

2023-2025 WIT Fellowship Grants and Inaugural LMIC Grants
for Research in Gender and Sex in Transplantation

The Women in Transplantation executive is very excited to announce the 2023 WIT funding opportunities. This year, we are thrilled to be able to support THREE 2-year Fellowships. This will be the third year that we are offering these fellowships.

In addition, for the first time, we are also offering ONE grant open to faculty working in low or middle income countries. This very special new grant will allow transplant professionals working in low and middle income countries to work with an experienced mentor from among the WIT membership to address an important question within their own unique context. We hope that this award will spur exciting international collaborations and build more research capacity in lower resource settings.

Research Fellowship Grants

Click here for more details

Grants for LMIC

Click here for more details

If you have any further questions and for information on how to apply, please contact Katie Tait (WIT Manager) at katie.tait@tts.org to request more information.